Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001245286 | SCV001418562 | uncertain significance | Ehlers-Danlos syndrome, type 4 | 2022-07-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL3A1 protein function. ClinVar contains an entry for this variant (Variation ID: 969848). This missense change has been observed in individual(s) with COL3A1-related conditions (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 185 of the COL3A1 protein (p.Pro185Ala). |
Baylor Genetics | RCV001330978 | SCV001522857 | uncertain significance | Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome | 2019-10-28 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
All of Us Research Program, |
RCV001245286 | SCV004826979 | uncertain significance | Ehlers-Danlos syndrome, type 4 | 2023-04-27 | criteria provided, single submitter | clinical testing |